Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Lockdown-born children show lower executive function at school age

14

Jul 2026

Lockdown-born children show lower executive function at school age

Children born during the first COVID-19 lockdown in England had lower reported levels of executive function - crucial skills involved in making plans, solving problems and adapting to new situations - suggest the findings of a study published online in the Archives of Disease in Childhood.

Fear of new foods may affect more than dietary variety

14

Jul 2026

Fear of new foods may affect more than dietary variety

Higher food neophobia was associated with poorer self-reported physical and mental health among 4,537 adults in Australia, the United Kingdom, and the United States. The relationship remained after accounting for age, gender, education, and country, although the cross-sectional study could not establish causation.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.